Cilnidipine decreases left atrial (LA) volume index superior than atenolol in the patients with hypertension
ViewFrequency of Urinary Tract Infections (UTIs) in Type 2 Diabetic Patients Taking Dapagliflozin
ViewTelmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial
ViewFixed dose combination of olmesartan and amlodipine in patients with hypertension and abdominal obesity. Data of 3-month observation of efficacy and adherence to therapy
ViewClinical diagnosis and Safety of Vildagliptin versus Sitagliptin with Metformin over Patients of Type-2 Diabetes Mellitus (T2DM)
ViewProspective Multicenter Observational Study of Voglibose in Type 2 Diabetes— VICTORY
ViewStatin treatment and muscle symptoms: series of randomized, placebo-controlled n-of-1 trials
ViewComparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With Dyslipidemia
ViewClinical diagnosis and safety of vildagliptin versus glimepiride with metformin over patients of type-2 diabetes mellitus
ViewLong-term effectiveness and safety of quadruple combination therapy with empagliflozin versus dapagliflozin in patients with type 2 diabetes: 3-year prospective observational study
View